Recovery Housing and Drug Abuse Treatment Outcome
Visão geral do estudo
Status
Descrição detalhada
Aims To conduct a randomized, controlled trial of abstinence-contingent recovery housing delivered with or without intensive day treatment among individuals exiting residential opioid detoxification.
Design Random assignment to one of three conditions: recovery housing alone (RH), abstinence-contingent recovery housing with reinforcement-based treatment RBT (RH + RBT) or usual care (UC). RH and RH + RBT participants received 12 weeks of paid recovery housing contingent upon drug abstinence. RH + RBT participants also received 26 weeks of RBT, initiated concurrently with recovery housing. Assessments were conducted at 1, 3 and 6 months after treatment enrollment.
Setting Out-patient drug-free substance abuse treatment program in Baltimore, Maryland.
Participants Patients (n = 243) who completed medication-assisted opioid detoxification.
Measurements Primary outcome was drug abstinence (opioid- and cocaine-negative urine and no self-reported opioid or cocaine use in the previous 30 days). Secondary outcomes included abstinence at all time-points (1, 3 and 6 months), days in recovery housing and employment.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21224
- Behavioral Pharmacology Research Unit
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- completes residential detoxification for use of opiates and/or cocaine
- willing to go to outpatient aftercare
- agrees to random assignment; signs informed consent
Exclusion Criteria:
- moving out of town
- primary substance use does not include opiates or cocaine
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Recovery housing plus counseling
Intensive counseling in a 5-day per week program plus abstinence-contingent rent payment in a community recovery house.
Intervention lasts 12 weeks with follow-up at 12 and 24 weeks post treatment entry.
|
Participants receive 3 months of abstinence-contingent program-supported rent payment in community recovery housing.
They also receive intensive outpatient counseling (both individual and group) focused on relapse prevention skills training, goal setting, employment seeking and recreational activities.
|
|
Experimental: Recovery Housing only
Abstinence-contingent payment for recovery housing rent in absence of any formal counseling.
Intervention lasts 12 weeks with follow-up at 12 and 24 weeks post treatment entry.
|
Participant may receive up to 3 months of abstinence-contingent rent payment in community recovery housing but is not invited to participate in intensive counseling.
|
|
Comparador Ativo: Usual Care Referral
Participants receive referral resources for community substance abuse counseling and recovery housing but no formal treatment or help with rent payments.
All participate in follow-up data collection.
|
Participants are referred to an outpatient program of their choosing with an appointment made for them.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
abstinence from opiates and cocaine
Prazo: 6 months post randomization
|
Free in the community plus self report of no drug use in past 30 days verified with negative urine screen.
|
6 months post randomization
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Maxine Stitzer, Ph.D., Johns Hopkins University
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- DA13003
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .